Cargando…
The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease
BACKGROUND: Charcot–Marie–Tooth disease (CMT) is a genetically and clinically heterogeneous group of inherited neuropathies. Monoallelic pathogenic variants in ATP1A1 were associated with axonal and intermediate CMT. ATP1A1 encodes for the catalytic α1 subunit of the Na(+)/ K(+) ATPase. Besides neur...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130110/ https://www.ncbi.nlm.nih.gov/pubmed/36738336 http://dx.doi.org/10.1007/s00415-023-11581-w |
_version_ | 1785030900036141056 |
---|---|
author | Cinarli Yuksel, Feride Nicolaou, Paschalis Spontarelli, Kerri Dohrn, Maike F. Rebelo, Adriana P. Koutsou, Pantelitsa Georghiou, Anthi Artigas, Pablo Züchner, Stephan L. Kleopa, Kleopas A. Christodoulou, Kyproula |
author_facet | Cinarli Yuksel, Feride Nicolaou, Paschalis Spontarelli, Kerri Dohrn, Maike F. Rebelo, Adriana P. Koutsou, Pantelitsa Georghiou, Anthi Artigas, Pablo Züchner, Stephan L. Kleopa, Kleopas A. Christodoulou, Kyproula |
author_sort | Cinarli Yuksel, Feride |
collection | PubMed |
description | BACKGROUND: Charcot–Marie–Tooth disease (CMT) is a genetically and clinically heterogeneous group of inherited neuropathies. Monoallelic pathogenic variants in ATP1A1 were associated with axonal and intermediate CMT. ATP1A1 encodes for the catalytic α1 subunit of the Na(+)/ K(+) ATPase. Besides neuropathy, other associated phenotypes are spastic paraplegia, intellectual disability, and renal hypomagnesemia. We hereby report the first demyelinating CMT case due to a novel ATP1A1 variant. METHODS: Whole-exome sequencing on the patient’s genomic DNA and Sanger sequencing to validate and confirm the segregation of the identified p.P600R ATP1A1 variation were performed. To evaluate functional effects, blood-derived mRNA and protein levels of ATP1A1 and the auxiliary β1 subunit encoded by ATP1B1 were investigated. The ouabain-survival assay was performed in transfected HEK cells to assess cell viability, and two-electrode voltage clamp studies were performed in Xenopus oocytes. RESULTS: The variant was absent in the local and global control datasets, falls within a highly conserved protein position, and is in a missense-constrained region. The expression levels of ATP1A1 and ATP1B1 were significantly reduced in the patient compared to healthy controls. Electrophysiology indicated that ATP1A1(p.P600R) injected Xenopus oocytes have reduced Na(+)/ K(+) ATPase function. Moreover, HEK cells transfected with a construct encoding ATP1A1(p.P600R) harbouring variants that confers ouabain insensitivity displayed a significant decrease in cell viability after ouabain treatment compared to the wild type, further supporting the pathogenicity of this variant. CONCLUSION: Our results further confirm the causative role of ATP1A1 in peripheral neuropathy and broaden the mutational and phenotypic spectrum of ATP1A1-associated CMT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-023-11581-w. |
format | Online Article Text |
id | pubmed-10130110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-101301102023-04-27 The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease Cinarli Yuksel, Feride Nicolaou, Paschalis Spontarelli, Kerri Dohrn, Maike F. Rebelo, Adriana P. Koutsou, Pantelitsa Georghiou, Anthi Artigas, Pablo Züchner, Stephan L. Kleopa, Kleopas A. Christodoulou, Kyproula J Neurol Original Communication BACKGROUND: Charcot–Marie–Tooth disease (CMT) is a genetically and clinically heterogeneous group of inherited neuropathies. Monoallelic pathogenic variants in ATP1A1 were associated with axonal and intermediate CMT. ATP1A1 encodes for the catalytic α1 subunit of the Na(+)/ K(+) ATPase. Besides neuropathy, other associated phenotypes are spastic paraplegia, intellectual disability, and renal hypomagnesemia. We hereby report the first demyelinating CMT case due to a novel ATP1A1 variant. METHODS: Whole-exome sequencing on the patient’s genomic DNA and Sanger sequencing to validate and confirm the segregation of the identified p.P600R ATP1A1 variation were performed. To evaluate functional effects, blood-derived mRNA and protein levels of ATP1A1 and the auxiliary β1 subunit encoded by ATP1B1 were investigated. The ouabain-survival assay was performed in transfected HEK cells to assess cell viability, and two-electrode voltage clamp studies were performed in Xenopus oocytes. RESULTS: The variant was absent in the local and global control datasets, falls within a highly conserved protein position, and is in a missense-constrained region. The expression levels of ATP1A1 and ATP1B1 were significantly reduced in the patient compared to healthy controls. Electrophysiology indicated that ATP1A1(p.P600R) injected Xenopus oocytes have reduced Na(+)/ K(+) ATPase function. Moreover, HEK cells transfected with a construct encoding ATP1A1(p.P600R) harbouring variants that confers ouabain insensitivity displayed a significant decrease in cell viability after ouabain treatment compared to the wild type, further supporting the pathogenicity of this variant. CONCLUSION: Our results further confirm the causative role of ATP1A1 in peripheral neuropathy and broaden the mutational and phenotypic spectrum of ATP1A1-associated CMT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-023-11581-w. Springer Berlin Heidelberg 2023-02-04 2023 /pmc/articles/PMC10130110/ /pubmed/36738336 http://dx.doi.org/10.1007/s00415-023-11581-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Communication Cinarli Yuksel, Feride Nicolaou, Paschalis Spontarelli, Kerri Dohrn, Maike F. Rebelo, Adriana P. Koutsou, Pantelitsa Georghiou, Anthi Artigas, Pablo Züchner, Stephan L. Kleopa, Kleopas A. Christodoulou, Kyproula The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title | The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title_full | The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title_fullStr | The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title_full_unstemmed | The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title_short | The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease |
title_sort | phenotypic spectrum of pathogenic atp1a1 variants expands: the novel p.p600r substitution causes demyelinating charcot–marie–tooth disease |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130110/ https://www.ncbi.nlm.nih.gov/pubmed/36738336 http://dx.doi.org/10.1007/s00415-023-11581-w |
work_keys_str_mv | AT cinarliyukselferide thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT nicolaoupaschalis thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT spontarellikerri thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT dohrnmaikef thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT rebeloadrianap thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT koutsoupantelitsa thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT georghiouanthi thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT artigaspablo thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT zuchnerstephanl thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT kleopakleopasa thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT christodouloukyproula thephenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT cinarliyukselferide phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT nicolaoupaschalis phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT spontarellikerri phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT dohrnmaikef phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT rebeloadrianap phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT koutsoupantelitsa phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT georghiouanthi phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT artigaspablo phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT zuchnerstephanl phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT kleopakleopasa phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease AT christodouloukyproula phenotypicspectrumofpathogenicatp1a1variantsexpandsthenovelpp600rsubstitutioncausesdemyelinatingcharcotmarietoothdisease |